Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	19134
Country	United States

Received	2015-04-29 08:54
Peer-Review Started	2015-05-07 20:12
To Make the First Decision	2015-10-14 11:19
Return for Revision	2015-10-15 10:25
Revised	2015-10-20 00:00
Second Decision	2015-11-23 17:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-12-04 16:06
Articles in Press	2015-12-04 16:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-09 16:49
Publish the Manuscript Online	2016-01-14 20:17

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Novel therapeutic agents in the treatment of metastatic colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Sachin Gopalkrishna Pai and Jyotsna Fuloria
Funding Agency and Grant Number
Corresponding Author	Jyotsna Fuloria, MD, Director, Department of Hematology and Oncology, Ochsner Medical Center, 1514 Jefferson Highway, New Orleans, LA 70121, United States. jfuloria@ochsner.org
Key Words	Metastatic colorectal cancer; Molecular targeted drugs; Anti-angiogenesis inhibitors; Epidermal growth factor receptor inhibitors; Novel therapeutic agents
Core Tip	This article reviews the novel agents in the management of metastatic colorectal cancer. The core principles and the evidence behind the use of these agents are discussed. Clinically relevant features are highlighted to help the health care provider involved in the care of metastatic colorectal cancer patients.
Publish Date	2016-01-14 20:17
Citation	Pai SG, Fuloria J. Novel therapeutic agents in the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2016; 8(1): 99-104
URL	http://www.wjgnet.com/1948-5204/full/v8/i1/99.htm
DOI	http://dx.doi.org/10.4251/wjgo.v8.i1.99

Full Article (PDF)	WJGO-8-99.pdf
Full Article (Word)	WJGO-8-99.doc
Manuscript File	19134-Review.docx
Answering Reviewers	19134-Answering reviewers.pdf
Audio Core Tip	19134-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19134-Conflict-of-interest statement.pdf
Copyright License Agreement	19134-Copyright assignment.pdf
Peer-review Report	19134-Peer-review(s).pdf
Scientific Misconduct Check	19134-Scientific misconduct check.pdf
Scientific Editor Work List	19134-Scientific editor work list.pdf